Stay updated with breaking news from Kodiak Sciences Inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
PALO ALTO, Calif., May 29, 2024 /PRNewswire/ -- Kodiak Sciences Inc. , a biopharmaceutical company committed to researching, developing and commercializing transformative therapeutics to treat a...
Shares of Kodiak Sciences Inc. (NASDAQ:KOD – Get Free Report) have received a consensus recommendation of “Reduce” from the seven analysts that are currently covering the firm, Marketbeat reports. Three investment analysts have rated the stock with a sell rating, three have issued a hold rating and one has given a buy rating to the […]
05:30/FRA: 1Q ILO Unemployment and Labour Market-related indicators 06:45/FRA: 1Q New home sales 08:30/UK: Feb Card Spending statistics 08:30/UK: Apr Monthly Insolvency statistics ... -May 17, 2024 at 06:25 am EDT - MarketScreener
Tarcocimab clinical and non-clinical data highlight strong 6-month efficacy profile in diabetic retinopathy patients and continued favorable safety profile.KSI-501 clinical and non-clinical data...
Acuitas Investments LLC lifted its holdings in shares of Kodiak Sciences Inc. (NASDAQ:KOD – Free Report) by 59.2% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 234,092 shares of the company’s stock after purchasing an additional 87,043 shares during the period. Acuitas […]